(0.77%) 5 057.19 points
(0.69%) 38 165 points
(1.38%) 15 820 points
(-0.04%) $78.97
(5.49%) $2.04
(0.07%) $2 312.70
(0.50%) $26.88
(0.79%) $962.40
(-0.06%) $0.932
(-0.28%) $11.00
(-0.07%) $0.798
(-1.36%) $91.99
@ $6.06
Išleistas: 14 vas. 2024 @ 21:25
Grąža: 0.25%
Ankstesnis signalas: vas. 14 - 21:05
Ankstesnis signalas:
Grąža: 1.08 %
Live Chart Being Loaded With Signals
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally...
Stats | |
---|---|
Šios dienos apimtis | 538 339 |
Vidutinė apimtis | 525 422 |
Rinkos kapitalizacija | 243.33M |
EPS | $0 ( 2024-04-04 ) |
Kita pelno data | ( $-0.190 ) 2024-07-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.270 |
ATR14 | $0.00500 (0.08%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Clemmer James C | Buy | 10 000 | Common Stock |
2024-02-29 | Trowbridge Stephen A | Buy | 1 927 | Common Stock |
2023-07-19 | Trowbridge Stephen A | Buy | 19 354 | Common Stock |
2023-07-19 | Trowbridge Stephen A | Sell | 6 975 | Common Stock |
2023-07-19 | Trowbridge Stephen A | Sell | 30 242 | Performance Right |
INSIDER POWER |
---|
44.80 |
Last 99 transactions |
Buy: 1 280 257 | Sell: 463 344 |
Tūris Koreliacija
AngioDynamics Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
WKEY | 0.947 |
INKT | 0.943 |
MBIO | 0.943 |
ULTA | 0.942 |
NMRD | 0.939 |
PHUN | 0.939 |
MINM | 0.939 |
WOOF | 0.938 |
PROG | 0.937 |
BGXX | 0.935 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
FXCO | -0.955 |
SNY | -0.948 |
XPDB | -0.937 |
MSDA | -0.935 |
GEEX | -0.935 |
PRSR | -0.933 |
IXAQ | -0.931 |
SGII | -0.929 |
UTAA | -0.928 |
FTII | -0.928 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
AngioDynamics Inc Koreliacija - Valiuta/Žaliavos
AngioDynamics Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $338.75M |
Bruto pelnas: | $174.25M (51.44 %) |
EPS: | $-1.330 |
FY | 2023 |
Pajamos: | $338.75M |
Bruto pelnas: | $174.25M (51.44 %) |
EPS: | $-1.330 |
FY | 2022 |
Pajamos: | $316.22M |
Bruto pelnas: | $165.73M (52.41 %) |
EPS: | $-0.680 |
FY | 2021 |
Pajamos: | $291.01M |
Bruto pelnas: | $156.79M (53.88 %) |
EPS: | $-0.820 |
Financial Reports:
No articles found.
AngioDynamics Inc
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.